ClinicalTrials.Veeva

Menu

A Study of a Lifestyle Program on Recurrent Atrial Fibrillation

Mayo Clinic logo

Mayo Clinic

Status

Withdrawn

Conditions

Atrial Fibrillation

Treatments

Behavioral: Multicomponent lifestyle intervention program

Study type

Interventional

Funder types

Other

Identifiers

NCT06155357
23-003042

Details and patient eligibility

About

The purpose of this study is to examine the impact of a comprehensive lifestyle intervention, including cardiac rehabilitation, prior to catheter ablation (a procedure to stop abnormal electrical signals in the heart), on Atrial Fibrillation (AF)-related symptoms.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Paroxysmal or persistent atrial fibrillation.
  • Planned elective catheter ablation of AF.

Exclusion criteria

  • Prior catheter ablation.
  • Presence of pacemaker/ICD.
  • Longstanding persistent AF.
  • Uncontrolled AF (including poor rate control or tachycardia-mediated cardiomyopathy requiring urgent cardioversion/ablation at the clinician's assessment).

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Lifestyle Interventions Pre-Procedure
Experimental group
Description:
Subjects with paroxysmal or persistent atrial fibrillation (AF) who are scheduled to undergo elective catheter ablation of AF will participate in a 12-week multicomponent lifestyle intervention program.
Treatment:
Behavioral: Multicomponent lifestyle intervention program
Standard of Care
No Intervention group
Description:
Subjects who have previously undergone catheter ablation of atrial fibrillation (AF) as part of their standard of care will have medical chart review completed to gather information.

Trial contacts and locations

1

Loading...

Central trial contact

Preventive/Vascular Research Team; Amanda Bonikowske, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems